— Know what they know.
Not Investment Advice
Also trades as: GLAXO.BO (BSE) · $vol 0M

GLAXO.NS NSE

GlaxoSmithKline Pharmaceuticals Limited
1W: -3.3% 1M: -3.7% 3M: -9.9% YTD: -10.9% 1Y: -15.3% 3Y: +89.4% 5Y: +77.8%
₹2,310.80 ($24.15)
-9.90 (-0.43%)
 
Weekly Expected Move ±3.0%
₹2283 ₹2356 ₹2429 ₹2501 ₹2574
NSE · Healthcare · Drug Manufacturers - General · Alpha Radar Sell · Power 33 · ₹390.8B mcap · 41M float · 0.155% daily turnover
Smart Money Score
Watch 0
Insider
Congress
ETF Holdings
Key Statistics
Market Cap₹390.8B ($4.1B)
52W Range2217.6-3515.7
Volume185,251
Avg Volume64,120
Beta0.10
Dividend₹42.00
Analyst Ratings
No analyst coverage
Company Info
CEOBhushan Akshikar
Employees3,211
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2002-07-01
GSK House
Mumbai 400030
IN
91 22 2495 9595
About GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited, a healthcare company, researches, develops, manufactures, and sells pharmaceutical medicines and vaccines in India and internationally. The company offers prescription and non-prescription drugs for anti-infective, respiratory, dermatology, nutrition, gastrointestinal, and rare diseases; and consumer healthcare products. It provides its product under the Augmentin, Calpol, Ceftum, Eltroxin, CCM, Neosporin, Betnovate, T-bact, Tenovate, Flutivate, Physiogel, Zimig, Cobadex CZS, Infanrix Hexa, Synflorix, Supacef, Havrix, Menveo, Boostrix, Fluarix Tetra, Varilrix, Nucala, and Trelegy Ellipta brands. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms